Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Saxton

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Vaccines|January 10, 2019
Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort StudyJanine Paynter, Felicity Goodyear-Smith, Jane Morgan, et al.
Vaccines|March 17, 2019
Reply to "Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005"Janine Paynter, Felicity Goodyear-Smith, Jane Morgan, et al.
The New Zealand Medical Journal|October 12, 2004
Living with HIV in New Zealand: balancing health and quality of lifeJeffrey Grierson, Marian Pitts, Matt Whyte, et al.
Pathology|September 10, 2023
Evaluating the sensitivity and specificity of dried blood spots for serological testing of HIV, syphilis, hepatitis B and C Elecsys assays on the Roche Cobas systemGary McAuliffe, Adri Gerber, Aakash Chhibber, et al.
Lancet (London, England)|July 15, 2017
Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control studyHelen Petousis-Harris, Janine Paynter, Jane Morgan, et al.
Vaccine|May 13, 2025
Mpox vaccine eligibility, uptake and coverage among gay, bisexual and other men who have sex with men in Aotearoa New ZealandPeter Saxton, Brooke Maria Hollingshead, Joe Rich, et al.
Sexually Transmitted Diseases|October 12, 2023
Sexually Transmitted Infections and the Risk of Reinfection Within 12 Months: A Population-Based CohortZoe Kumbaroff, Putu Duff, Peter Saxton, et al.
The New Zealand Medical Journal|August 31, 2018
Implementing HIV pre-exposure prophylaxis (PrEP): let's not get caught with our pants downPeter Saxton, Massimo Giola, Edward Coughlan, et al.
Sexual Health|December 11, 2014
A novel response to an outbreak of infectious syphilis in Christchurch, New ZealandEdward Coughlan, Heather Young, Catherine Parkes, et al.
AIDS and Behavior|March 30, 2021
Changes in Sexual Behaviour Following PrEP Initiation Among Australian Gay and Bisexual Men in Relationships: Results from a Prospective Observational StudyBenjamin R Bavinton, Mohamed A Hammoud, Martin Holt, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Vaccines|January 10, 2019
Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort StudyJanine Paynter, Felicity Goodyear-Smith, Jane Morgan, et al.
Vaccines|March 17, 2019
Reply to "Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005"Janine Paynter, Felicity Goodyear-Smith, Jane Morgan, et al.
The New Zealand Medical Journal|October 12, 2004
Living with HIV in New Zealand: balancing health and quality of lifeJeffrey Grierson, Marian Pitts, Matt Whyte, et al.
Pathology|September 10, 2023
Evaluating the sensitivity and specificity of dried blood spots for serological testing of HIV, syphilis, hepatitis B and C Elecsys assays on the Roche Cobas systemGary McAuliffe, Adri Gerber, Aakash Chhibber, et al.
Lancet (London, England)|July 15, 2017
Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control studyHelen Petousis-Harris, Janine Paynter, Jane Morgan, et al.
Vaccine|May 13, 2025
Mpox vaccine eligibility, uptake and coverage among gay, bisexual and other men who have sex with men in Aotearoa New ZealandPeter Saxton, Brooke Maria Hollingshead, Joe Rich, et al.
Sexually Transmitted Diseases|October 12, 2023
Sexually Transmitted Infections and the Risk of Reinfection Within 12 Months: A Population-Based CohortZoe Kumbaroff, Putu Duff, Peter Saxton, et al.
The New Zealand Medical Journal|August 31, 2018
Implementing HIV pre-exposure prophylaxis (PrEP): let's not get caught with our pants downPeter Saxton, Massimo Giola, Edward Coughlan, et al.
Sexual Health|December 11, 2014
A novel response to an outbreak of infectious syphilis in Christchurch, New ZealandEdward Coughlan, Heather Young, Catherine Parkes, et al.
AIDS and Behavior|March 30, 2021
Changes in Sexual Behaviour Following PrEP Initiation Among Australian Gay and Bisexual Men in Relationships: Results from a Prospective Observational StudyBenjamin R Bavinton, Mohamed A Hammoud, Martin Holt, et al.
Pageof 4